Atypical Central Serous Chorioretinopathy

Overview

Journal Turk J Ophthalmol

Specialty Ophthalmology

Date 2017 Aug 29

PMID 28845331

Citations 6

Authors

Zafer Cebeci

Merih Oray

Serife Bayraktar

Ilknur Tugal-Tutkun

Nur Kir

Affiliations

Soon will be listed here.

Abstract

Bullous central serous chorioretinopathy (CSCR) is a rare variant of CSCR characterized by severe serous retinal detachment which especially involves the inferior quadrants. Corticosteroid therapy administered for systemic or ocular misdiagnoses may induce and exacerbate CSCR. The purpose of this study was to report diagnosis and treatment results of an unusual case of bullous CSCR induced by systemic and periocular corticosteroid therapy received at another medical center due to a misdiagnosis of Vogt-Koyanagi-Harada disease.

Citing Articles

Surgical Treatment of Bullous Exudative Retinal Detachment Secondary to Atypical Bilateral Central Serous Chorioretinopathy.

Ozdemir H, Yuksel M, Hasanreisoglu M, Gurelik G, Sarici A, Tugal-Tutkun I Turk J Ophthalmol. 2023; 53(6):395-398.

PMID: 38014882 PMC: 10750088. DOI: 10.4274/tjo.galenos.2023.75233.

Bilateral bullous central serous chorioretinopathy treated with PDT and eplerenone.

Anderson W, Smith B Am J Ophthalmol Case Rep. 2022; 28:101739.

PMID: 36393907 PMC: 9640324. DOI: 10.1016/j.ajoc.2022.101739.

Atypical Chronic Central Serous Chorioretinopathy Mimicking Vogt-Koyanagi-Harada Disease: Full Therapeutic Response to Half-Fluence Photodynamic Therapy.

Yanik O, Batioglu F, Yalcindag N, Demirel S, Ozmert E Turk J Ophthalmol. 2022; 52(2):147-152.

PMID: 35481737 PMC: 9069095. DOI: 10.4274/tjo.galenos.2022.93213.

Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review.

Sartini F, Menchini M, Posarelli C, Casini G, Figus M Pharmaceuticals (Basel). 2020; 13(9).

PMID: 32872388 PMC: 7559580. DOI: 10.3390/ph13090221.

Central Serous Chorioretinopathy: A Complication Associated with Behçet’s Disease Treatment.

Doganay N, Yilmaz M, Orduyilmaz B, Aydin E, Saatci A Turk J Ophthalmol. 2019; 49(1):40-43.

PMID: 30829024 PMC: 6416479. DOI: 10.4274/tjo.galenos.2018.83479.

References

GASS J, Little H . Bilateral bullous exudative retinal detachment complicating idiopathic central serous chorioretinopathy during systemic corticosteroid therapy. Ophthalmology. 1995; 102(5):737-47. DOI: 10.1016/s0161-6420(95)30960-8. View

Chan W, Lam D, Lai T, Tam B, Liu D, Chan C . Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green guided photodynamic therapy with verteporfin: a novel treatment at the primary disease level. Br J Ophthalmol. 2003; 87(12):1453-8. PMC: 1920573. DOI: 10.1136/bjo.87.12.1453. View

Smretschnig E, Ansari-Shahrezaei S, Hagen S, Glittenberg C, Krebs I, Binder S . Half-fluence photodynamic therapy in chronic central serous chorioretinopathy. Retina. 2013; 33(2):316-23. DOI: 10.1097/IAE.0b013e318280769c. View

Ng W, Wu Z, Lai T . Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report. J Med Case Rep. 2011; 5:208. PMC: 3118209. DOI: 10.1186/1752-1947-5-208. View

GASS J . Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy. Am J Ophthalmol. 1973; 75(5):810-21. DOI: 10.1016/0002-9394(73)90887-8. View

Gao X, Li X . Development of bullous retinal detachment during systemic corticosteroid treatment. Graefes Arch Clin Exp Ophthalmol. 2010; 249(12):1905-7. DOI: 10.1007/s00417-010-1582-8. View

Nicholson B, Noble J, Forooghian F, Meyerle C . Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013; 58(2):103-26. PMC: 3574296. DOI: 10.1016/j.survophthal.2012.07.004. View

Salz D, Pitcher 3rd J, Hsu J, Regillo C, Fineman M, Elliott K . Oral eplerenone for treatment of chronic central serous chorioretinopathy: a case series. Ophthalmic Surg Lasers Imaging Retina. 2015; 46(4):439-44. DOI: 10.3928/23258160-20150422-06. View

Kang J, Kim H, Boo H, Kim H, Lee J . Surgical management of bilateral exudative retinal detachment associated with central serous chorioretinopathy. Korean J Ophthalmol. 2006; 20(2):131-8. PMC: 2908829. DOI: 10.3341/kjo.2006.20.2.131. View

10.

Otsuka S, Ohba N, Nakao K . A long-term follow-up study of severe variant of central serous chorioretinopathy. Retina. 2002; 22(1):25-32. DOI: 10.1097/00006982-200202000-00005. View

11.

Khairallah M, Kahloun R, Tugal-Tutkun I . Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm. 2012; 20(2):76-85. DOI: 10.3109/09273948.2011.650776. View

12.

Sahu D, Namperumalsamy P, HILTON G, de Sousa N . Bullous variant of idiopathic central serous chorioretinopathy. Br J Ophthalmol. 2000; 84(5):485-92. PMC: 1723484. DOI: 10.1136/bjo.84.5.485. View

13.

Bouzas E, Karadimas P, Pournaras C . Central serous chorioretinopathy and glucocorticoids. Surv Ophthalmol. 2002; 47(5):431-48. DOI: 10.1016/s0039-6257(02)00338-7. View

14.

Cunningham Jr E, Rathinam S, Tugal-Tutkun I, Muccioli C, Zierhut M . Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2014; 22(4):249-52. DOI: 10.3109/09273948.2014.939530. View

15.

Singh R, Sears J, Bedi R, Schachat A, Ehlers J, Kaiser P . Oral eplerenone for the management of chronic central serous chorioretinopathy. Int J Ophthalmol. 2015; 8(2):310-4. PMC: 4413566. DOI: 10.3980/j.issn.2222-3959.2015.02.17. View

16.

Chhablani J, Wong I, Kozak I . Choroidal imaging: A review. Saudi J Ophthalmol. 2014; 28(2):123-8. PMC: 4023115. DOI: 10.1016/j.sjopt.2014.03.004. View